Current role
Biotechnology · Healthcare
Chairman, Board Member
2009-01-01–present
Jeffrey Leiden
Chairman
Vertex Pharmaceuticals Inc (VRTX)Board Member
Vertex Pharmaceuticals Inc (VRTX)Equibles does not estimate personal net worth.
Get an email with a short summary when Vertex Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get VRTX alertsAbout Jeffrey Leiden
Jeffrey Leiden is recorded as Board Member at Vertex Pharmaceuticals Inc (VRTX) since January 1, 2009 and Chairman at Vertex Pharmaceuticals Inc (VRTX). The newest filing on record that lists Jeffrey Leiden as Board Member at Vertex Pharmaceuticals Inc (VRTX) is dated April 2, 2026. The newest filing on record that lists Jeffrey Leiden as Chairman at Vertex Pharmaceuticals Inc (VRTX) is dated April 4, 2024. The proxy statement of Vertex Pharmaceuticals Inc reports total compensation of $6,595,282 for Jeffrey Leiden in fiscal 2023. Disclosed compensation is on record for 7 fiscal years. Vertex Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vertex Pharmaceuticals Inc includes Dr. Reshma Kewalramani (CEO), Reshma Kewalramani (CEO and Board Member), Dr. Jeffrey M. Leiden (Chairman) and 7 others.
Affiliation history
-
Current
2009-01-01–present
Last confirmed April 2, 2026
-
Current
Start not stated–present
Last confirmed April 4, 2024
-
Start not stated–2021-04-08
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Vertex Pharmaceuticals Inc
- Dr. Reshma Kewalramani CEO
- Reshma Kewalramani CEO, Board Member
- Dr. Jeffrey M. Leiden Chairman
- Charles Wagner CFO
- Jonathan Poole CFO
- Charles F. Wagner, Jr. COO
- Alan Garber Board Member
- Bruce Sachs Board Member
- Daniel Brennan Board Member
- Diana McKenzie Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Vertex Pharmaceuticals Inc (VRTX) | Executive Chairman | — | $6,595,282 |
| 2022 | Vertex Pharmaceuticals Inc (VRTX) | Executive Chairman | — | $8,593,180 |
| 2021 | Vertex Pharmaceuticals Inc (VRTX) | Executive Chairman | $242,308 | $8,157,239 |
| 2020 | Vertex Pharmaceuticals Inc (VRTX) | Executive Chairman | $1,121,539 | $16,473,245 |
| 2019 | Vertex Pharmaceuticals Inc (VRTX) | Executive Chairman | $1,300,000 | $18,789,985 |
| 2018 | Vertex Pharmaceuticals Inc (VRTX) | Executive Chairman (CEO and President through March 31, 2020) | $1,300,000 | $18,799,147 |
| 2017 | Vertex Pharmaceuticals Inc (VRTX) | Executive Chairman (CEO and President through March 31, 2020) | $1,300,000 | $17,227,301 |
Recent activity
No call appearances or filed executive changes recorded yet.